 OraSure Technologies, Inc. OSUR, a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services is introducing the first and only commercially available device for in-home, self-collection of fecal samples for metabolomics. A product of OraSures DNA Genotek subsidiary, the OMNImetTMGUT ME-200 augments the Companys portfolio of multiomic sample collection products. Advances in the prediction, detection, understanding, and monitoring of human diseases have increased the use of metabolomics technologies, said Kathleen Weber, Executive Vice President, Business Unit Leader, Molecular Solutions at DNA Genotek. 